Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,036
Closed -$81.5K 651
2025
Q4
$81.5K Buy
+18,036
New +$92.4K 0.01% 513

DGS Capital Management's CVAC Position: Q1 2026 in Review

DGS Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 18,036 shares — an estimated $81.5K sold.

DGS Capital Management first reported a position in CVAC in Q4 2025 and held it in 1 quarter. The position peaked at $81.5K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • DGS Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • DGS Capital Management sold 18,036 CureVac shares in Q1 2026, an estimated $81.5K.
  • DGS Capital Management first reported a position in CureVac in Q4 2025 and held it in 1 quarter.
  • DGS Capital Management's CureVac position peaked at $81.5K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.